Compared with anemia controls (AC), the CD36 CV in MDS significantly increased (median 71.1 vs. 56.1, P = 0.002) and CD36 RMFI of CD105+ NEC was significantly decreased (median 360 vs. 512, P = 0.003). This evidence concerns the gene CD36 and myelodysplastic syndrome.